Ben-Gurion University of the Negev Research and Development Authority
发明人:
Arik DAHAN
申请号：
US14536703
公开号：
US20150065462A1
申请日:
2014.11.10
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Conjugates of drugs suitable for use in the treatment of inflammatory bowel disease and phospholipids, and their use in the treatment of inflammatory bowel disease, are disclosed. The disclosed conjugates serve as targeted prodrugs which are suitable for oral administration, and which are capable of releasing the drug selectively at the diseased tissue upon activation by PLA2.
